Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Case Study: Teva and Suns At-Risk Pantoprazole Launch A $2.15 Billion Lesson In 2007, generic manufacturers Teva and Sun Pharmaceutical Industries were so confident in their invalidity arguments against Wyeths pantoprazole (Protonix) patents that they launched their generic versions at risk meaning commercial sales began while the underlying patent infringement case was still pending in federal court
10.1038/nrrheum.2013.14 Nat
L., Gupta, S
The Link Between L-Carnitine and Autism: Research has shown that individuals with autism often have lower levels of L-carnitine compared to their neurotypical counterparts
US$ 25.90
US$ 26.90
US$ 26.69
